Tags:CareDeviceDrugHealthMedicalMedTechTechnology
Nuvaira has developed the Nuvaira Lung Denervation System to treat patients with chronic obstructive pulmonary disease (COPD) refractory to drug therapy.
Location: United States, Minneapolis
Total raised: $79M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
11.02.2019-$79M--

Mentions in press and media 10

DateTitleDescriptionCategoryAuthorSource
11.08.2021Nuvaira An... MINNEAPOLIS, Aug. 11, 2021 /...--prnewswire...
23.11.2020Nuvaira An... MINNEAPOLIS, Nov. 23, 2020 /...--prnewswire...
21.07.2020Seattle-ar...Medical device startup CurvaFi...-Taylor Sop...geekwire.c...
13.02.2019Term Sheet...5 Qs WITH A DEALMAKER Good mo...--fortune.co...
13.02.2019Minneapoli...Nuvaira, a Minneapolis, Minnes...--pulse2.com...
12.02.2019Daily fund...Zoovu $14M; Chainalysis raised...-Kristin Ka...vator.tv/n...
11.02.2019Nuvaira Ra...Nuvaira, a Minneapolis, Minn.-...USA-finsmes.co...
11.02.2019Nuvaira ra...Nuvaira has raised $79 million...MedTech-fiercebiot...
11.02.2019Nuvaira An...---lightstone...
11.02.2019Nuvaira An...---usvp.com/n...